ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma

Zhang, Qiong; Ning, Gang; Jiang, Hongye; Huang, Yanlin; Piao, Jinsong; Chen, Zhen; Tan, Xiaojun*; Zhang, Jiangyu*; Liu, Genglong*广州医学院; 南方医科大学; 中山大学; 1
DISEASE MARKERS2020-12-1DOI: 10.1155/2020/9180732
10被引10阅读
引用收藏
分享

摘要

Background. Our study aims to develop a lncRNA-based classifier and a nomogram incorporating the genomic signature and clinicopathologic factors to help to improve the accuracy of recurrence prediction for hepatocellular carcinoma (HCC) patients. Methods. The lncRNA profiling data of 374 HCC patients and 50 normal healthy controls were downloaded from The Cancer Genome Atlas (TCGA). Using univariable Cox regression and least absolute shrinkage and selection operator (LASSO) analysis, we developed a 15-lncRNA-based classifier and compared our classifier to the existing six-lncRNA signature. Besides, a nomogram incorporating the genomic classifier and clinicopathologic factors was also developed. The predictive accuracy and discriminative ability of the genomic-clinicopathologic nomogram were determined by a concordance index (C-index) and calibration curve and were compared with the TNM staging system by the C-index and receiver operating characteristic (ROC) analysis. Decision curve analysis (DCA) was performed to estimate the clinical value of our nomogram. Results. Fifteen relapse-free survival (RFS-) related lncRNAs were identified, and the classifier, consisting of the identified 15 lncRNAs, could effectively classify patients into the high-risk and low-risk subgroups. The prediction accuracy of the 15-lncRNA-based classifier for predicting 2-year and 5-year RFS was 0.791 and 0.834 in the training set and 0.684 and 0.747 in the validation set, respectively, which was better than the existing six-lncRNA signature. Moreover, the AUC of genomic-clinicopathologic nomogram in predicting RFS were 0.837 in the training set and 0.753 in the validation set, and the C-index of the genomic-clinicopathologic nomogram was 0.78 (0.72-0.83) in the training set and 0.71 (0.65-0.76) in the validation set, which was better than the traditional TNM stage and 15-lncRNA-based classifier. The decision curve analysis further demonstrated that our nomogram had a larger net benefit than the TNM stage and 15-lncRNA-based classifier. The results were confirmed externally. Conclusion. Compared to the TNM stage, the 15-lncRNAs-based classifier-clinicopathologic nomogram is a more effective and valuable tool to identify HCC recurrence and may aid in clinical decision-making.

学科与关键词

关键词
GASTRIC-CANCERFREE SURVIVALPROGRESSIONRESECTIONPROGNOSISPATTERNS
相关
加载中…
  • Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival
    Ma, Lidi; Deng, Kan; Zhang, Cheng; Li, Haixia; Luo, Yingwei; Yang, Yingsi; Li, Congrui; Li, Xinming*; Geng, Zhijun*; Xie, Chuanmiao*Frontiers in Oncology, 2022, 12: 843589.被引 12
  • A New Prognostic Strategy Based on four DNA Repair-Associated lncRNAs for Hepatocellular Carcinoma
    Zeng, Hanyi; Liu, Chengdong; Zhou, Xiaohan; Liu, Li*COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2022, 25(5): 906-918.被引 4
  • Prediction of early recurrence of hepatocellular carcinoma after liver transplantation based on computed tomography radiomics nomogram
    Zhao, Jing-Wei; Shu, Xin; Chen, Xiao-Xia; Liu, Jia-Xiong; Liu, Mu-Qing; Ye, Ju; Jiang, Hui-Jie; Wang, Gui-Sheng*Hepatobiliary & Pancreatic Diseases International, 2022, 21(6): 543-550.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
DISEASE MARKERS
发表日期
2020-12-01
卷期
第 2020 卷
页码
9180732
DOI
10.1155/2020/9180732
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
4区
成果收录
SCIE

作者

  • Z

    Zhang, Qiong (第一作者)

    guangzhou med univ

  • N

    Ning, Gang

    1

查看全部 9 位作者收起作者
  • J

    Jiang, Hongye

    1 · southern med univ

  • H

    Huang, Yanlin

    sun yat sen univ

  • P

    Piao, Jinsong

    guangzhou med univ

  • C

    Chen, Zhen

    1 · southern med univ

  • T

    Tan, Xiaojun (通讯)

    guangzhou med univ

  • Z

    Zhang, Jiangyu (通讯)

    guangzhou med univ

  • L

    Liu, Genglong (通讯)

    guangzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417